Skip to main content
Recall Canary
Arvis Hip & Knee 3.0 Instrument Set
← Back to all recalls
MEDICAL DEVICE RECALLMODERATE

Arvis Hip & Knee 3.0 Instrument Set

Kico recalls Arvis Hip & Knee 3.0 Instrument Set over magnet face wear/corrosion.

What to do

Stop using the affected instrument set and contact Kico Knee Innovation Company for instructions on returning the device for inspection and replacement.

Recalled
Listed
Updated
Recall No.
Z-2292-2026
Agency
FDA
Firm
Kico Knee Innovation Company
Recall ID
98804
Status
ONGOING

Why it was recalled

Kico Knee Innovation Company is recalling the Arvis Hip & Knee 3.0 Instrument Set (REF: IN-28000) because the V-Block Assembly and Trackers A, B, C, and E may exhibit early wear and/or corrosion on the exposed magnet face, which could affect surgical accuracy. The affected components are IN-10500, IN-10600, IN-16400, IN-16100, and IN-28050.

Is mine affected?

Check the model, lot, or serial number on the device or its packaging. Yours is affected if it matches one below.

Lot code: All Lots/serial Numbers

ProductRecall #UDI-DI
Arvis Hip & Knee 3.0 Instrument Set, REF: IN-28000 containing one of the following components: IN-10500, Impactor V-Block Assembly; IN-10600 , Tracker B; IN-16400, Tracker A; IN-16100, Tracker C; IN-28050, Tracker EZ-2292-202600810180350020, 00810180350686, 00810180350693, 00810180350525, 00810180350563, 00810180350051
Arvis Hip & Knee 2.0 Instrument Set, REF: IN-21200 containing one of the following components: IN-10500, Impactor V-Block Assembly; IN-10600 , Tracker B; IN-16400, Tracker A; IN-16100, Tracker CZ-2293-202600810180350020, 00810180350686, 00810180350693, 00810180350525, 00810180350563

Where it was sold

Distributed nationwide.

Timeline

  1. Firm initiated recall
  2. Publicly announced
  3. Listed on Recall Canary
  4. Summary updated

Other recent recalls from Kico Knee Innovation Company

All recalls from Kico Knee Innovation Company

← Back to all recalls

Editorial summary by Recall Canary · summary updated 2026-09-08 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification